Introducing Clinically Proven MelaFind®: Medical Imaging Device
MelaFind was designed by dermatologists and is ONLY for dermatologists. Clinically proven to have a very high sensitivity to melanoma and high grade lesions, MelaFind® offers dermatologists objective information about the 3-dimensional morphological disorganization of atypical pigmented skin lesions from under the skin. This new information requires no interpretation, but rather, incorporation of the MelaFind® data, which allows for a more informed biopsy decision.
Click here for important safety information about MelaFind®.
New MelaFind®
MelaFind® is pioneering medical technology as the world's first dermatologic analysis system (for dermatologists only) that sees below the skin's surface to objectively evaluate clinically atypical pigmented skin lesions (PSLs) and classify them based on the level of 3-dimensional morphological disorganization from under the skin.
Click here for important safety information about MelaFind®.
Introducing CE Mark and FDA approved MelaFind®
New clinically proven MelaFind® provides information within a minute about the disorganization of clinically atypical pigmented skin lesions, so for the first time ever, dermatologists can use an objective, rigorously studied and validated evaluation to inform their biopsy decision. MelaFind was designed by dermatologists and is ONLY for dermatologists.
Click here for important safety information about MelaFind®.